Yes, I think you're correct with that enkayess. I do however think that there are various grants which they can now apply for through the FDA, so I would like to know if they intend to apply for the ones relevant to neurodegenerative diseases.
Also, the seven years exclusivity for marketing MPL will only kick in once we have full approval, so not a money maker now but will certainly be attractive to anyone looking at the long game and thinking of helping us out with a bit of funding.
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-118
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.46M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 18.5¢ | $177.2K | 929.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 499621 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |